Study supports HPV (human papillomavirus) testing for equivocal cervical smears
This article was originally published in Clinica
A major US cervical cancer screening trial has produced strong evidence to show that testing for the human papillomavirus (HPV) in women with inconclusive cervical Pap smears is a viable means of identifying those who may be spared unnecessary colposcopy and follow-up.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.